The DOI matches its Crossref record.
Ciprofloxacin Inhibition of Experimental Fracture-Healing*
Abstract
BACKGROUND: Fluoroquinolones, such as ciprofloxacin, have an adverse effect on growing cartilage and endochondral ossification in children. This study was carried out to determine whether ciprofloxacin also has an adverse effect on the healing of experimental fractures. METHODS: Sixty male 300-gram Wistar rats were divided equally into three groups, which received ciprofloxacin, cefazolin, or no treatment for three weeks, beginning seven days after production of a closed, nondisplaced, bilateral femoral fracture. The serum concentrations of the ciprofloxacin and the cefazolin were 2.4 and 146 micrograms per milliliter, respectively. Radiographic, histological, and biomechanical studies were used to evaluate fracture-healing. RESULTS: Radiographs revealed significantly more advanced healing of the control fractures compared with the fractures in the ciprofloxacin-treated group (average stage, 2.1 compared with 1.5, p = 0.01). The cefazolin-treated group was not different from the controls with respect to radiographic healing (average stage, 1.8 compared with 2.1, p = 0.18). Torsional strength-testing of fracture callus exposed to ciprofloxacin revealed a 16 percent decrease in strength compared with the controls (284 compared with 338 newton-millimeters, p = 0.04) and a 49 percent decrease in stiffness (twenty compared with thirty-nine newton-millimeters per degree, p = 0.001). The biomechanical strength in the cefazolin-treated group was not different from that of the controls. Fracture calluses in the animals treated with ciprofloxacin showed abnormalities in cartilage morphology and endochondral bone formation and a significant decrease in the number of chondrocytes compared with the controls (0.77 x 10(4) compared with 1.3 x 10(4) cells per square millimeter, p = 0.004). CONCLUSIONS: These data suggest that experimental fractures exposed to therapeutic concentrations of ciprofloxacin in serum demonstrate diminished healing during the early stages of fracture repair. The administration of ciprofloxacin during early fracture repair may compromise the clinical course of fracture-healing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Treatment of critical-sized bone defects: clinical and tissue engineering perspectives
Roddy, E., DeBaun, M. R., Daoud-Gray, A., Yang, Y. P., & Gardner, M. J. (2018) · European Journal of Orthopaedic Surgery & Traumatology · doi:10.1007/s00590-017-2063-0 · Cited by 459
Inhibition of fracture healing
Gaston, M. S., & Simpson, A. H. R. W. (2007) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.89b12.19671 · Cited by 380
Effect of various concentrations of antibiotics on osteogenic cell viability and activity
Rathbone, C. R., Cross, J. D., Brown, K. V., Murray, C. K., & Wenke, J. C. (2011) · Journal of Orthopaedic Research · doi:10.1002/jor.21343 · Cited by 344
Pharmacological agents and impairment of fracture healing: What is the evidence?
Pountos, I., Georgouli, T., Blokhuis, T. J., Pape, H. C., & Giannoudis, P. V. (2008) · Injury · doi:10.1016/j.injury.2007.10.035 · Cited by 168
Aspenberg, P. (2005) · Acta Orthopaedica · doi:10.1080/17453670510045318 · Cited by 97
Metadata
- Authors
- HUDDLESTON, P. M., STECKELBERG, J. M., HANSSEN, A. D., ROUSE, M. S., BOLANDER, M. E., & PATEL, R.
- Venue
- The Journal of Bone and Joint Surgery-American Volume
- Published
- 2000-02
- Volume
- 82
- Issue
- 2
- Pages
- 161-173
- ISSN
- 0021-9355 (ISSN-L)
- OpenAlex
- W60764861
- Cited by
- 191
- References
- 0
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ciprofloxacin Inhibition of Experimental Fracture-Healing*. https://app.cochat.ai/papers/10.2106/00004623-200002000-00002
- The paper
- HUDDLESTON, P. M., STECKELBERG, J. M., HANSSEN, A. D., ROUSE, M. S., BOLANDER, M. E., & PATEL, R. (2000). Ciprofloxacin Inhibition of Experimental Fracture-Healing*. The Journal of Bone and Joint Surgery-American Volume. https://doi.org/10.2106/00004623-200002000-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.